Cargando…
Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin‐4‐expressing pancreatic cancer cells
Pancreatic cancer is one of the most intractable cancers and has a devastating prognosis; over the past three decades the 5‐year survival rate has been <10%. Therefore, development of a novel anticancer treatment for pancreatic cancer is a matter of urgency. We previously developed an oncolytic r...
Autores principales: | Awano, Mutsumi, Fujiyuki, Tomoko, Shoji, Koichiro, Amagai, Yosuke, Murakami, Yoshinori, Furukawa, Yoichi, Sato, Hiroki, Yoneda, Misako, Kai, Chieko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132336/ https://www.ncbi.nlm.nih.gov/pubmed/27561180 http://dx.doi.org/10.1111/cas.13064 |
Ejemplares similares
-
Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy
por: Fujiyuki, Tomoko, et al.
Publicado: (2020) -
Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells
por: Amagai, Yosuke, et al.
Publicado: (2016) -
A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells
por: Fujiyuki, Tomoko, et al.
Publicado: (2015) -
Immune response elicited in the tumor microenvironment upon rMV‐SLAMblind cancer virotherapy
por: Moritoh, Kanako, et al.
Publicado: (2023) -
Development of new therapy for canine mammary cancer with recombinant measles virus
por: Shoji, Koichiro, et al.
Publicado: (2016)